To cite this paper use one of the standards below:
Doxorubicin (DOXO) is an anthracycline chemotherapeutic widely used to treat cancers such as breast cancer, carcinomas, sarcomas, and hematologic malignancies. Hydroxyapatite (HA) and zinc-substituted hydroxyapatite (ZnHA) are nanostructured, biocompatible, and osteoconductive biomaterials. This study investigates the adsorption of DOXO onto HA and ZnHA powders as an alternative drug delivery system to enhance efficacy and reduce adverse effects. Adsorption was evaluated over 24 hours using 100 mg of HA or ZnHA with DOXO solutions (0.05–2.0 mg/mL). DOXO quantification was performed by UV-vis spectrophotometry at 490 nm, based on residual concentrations in the supernatant. Adsorption isotherms were constructed and fitted to Langmuir, Freundlich, and Langmuir–Freundlich models using Origin software. Materials were characterised by Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and thermogravimetric analysis coupled with differential thermal analysis (TG-DTA). Cytocompatibility was assessed using Live/Dead and PrestoBlue assays on MG63 osteoblast-like cells exposed to DOXO-loaded HA and ZnHA, analysed by fluorescence microscopy. DOXO adsorption showed high incorporation efficiencies: 91% for HA and 96% for ZnHA, corresponding to ~38 mg and ~39 mg DOXO per gram, respectively. The Langmuir–Freundlich model best described the adsorption mechanism, suggesting multilayer adsorption. FTIR, XRD, and TG-DTA confirmed drug incorporation while maintaining nanoparticle structural integrity. Cytocompatibility assays indicated low cytotoxicity for solid DOXO/HA and DOXO/ZnHA, whereas extracts collected 24 hours after exposure induced significant cell death. These findings highlight the potential of HA and ZnHA nanoparticles as doxorubicin delivery systems for bone tumour treatment.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper